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Lymphocyte migration is a key step in the
host’s immune response against viruses.
Mohammed et al. demonstrate that re-
expressed L-selectin/CD62L on primed
virus-specific CD8+ T cells plays a pivotal
role in their recruitment from the
bloodstream into virus-infected tissues
for protective immunity.
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Cytotoxic CD8+ T lymphocytes play a critical role in
the host response to infection by viruses. The ability
to secrete cytotoxic chemicals and cytokines is
considered pivotal for eliminating virus. Of equal
importance is how effector CD8+ T cells home to
virus-infected tissues. L-selectin has not been
considered important for effector T cell homing,
because levels are low on activated T cells.We report
here that, although L-selectin expression is down-
regulated following T cell priming in lymph nodes,
L-selectin is re-expressed on activated CD8+ T cells
entering the bloodstream, and recruitment of
activated CD8+ T cells from the bloodstream into
virus-infected tissues is L-selectin dependent.
Furthermore, L-selectin on effector CD8+ T cells
confers protective immunity to two evolutionally
distinct viruses, vaccinia and influenza, which
infect mucosal and visceral organs, respectively.
These results connect homing and a function of
virus-specific CD8+ T cells to a single molecule,
L-selectin.
INTRODUCTION
CD8+ T cells play a prominent role in the host response to infec-
tion with a variety of pathogens, most notably, viruses. The acti-
vation, proliferation, and differentiation of naive CD8+ T cells into
effector cytotoxic T cells have been studied extensively in mice
in response to a number of different viruses, using various routes
of inoculation (Fung-Leung et al., 1991; Goulding et al., 2014;
Zinkernagel and Doherty, 1979). The consensus from these
studies is that effector CD8+ T cells are generated from naive
CD8+ T cells inside lymphoid organs draining the site of virus
inoculation. Following exit from the lymph node (LN) and entry
into the bloodstream, effector CD8+ T cells migrate to virus-in-
fected tissues in response to inflammatory stimuli produced by
the virus to clear/resolve the infection. Effector CD8+ T cells760 Cell Reports 14, 760–771, February 2, 2016 ª2016 The Authorsalso migrate to many different non-lymphoid organs that are
not infected by virus (Masopust et al., 2004). The widespread
dissemination of virus-specific CD8+ T cells to tissues in which
they are not needed may limit the number available to clear virus
from infected organs and thereby reduce their efficacy. Exten-
sive studies have elucidated the different mechanisms that
effector CD8+ T cells use to eliminate virus (Zhang and Bevan,
2011). However, the recruitment of virus-specific effector CD8+
T cells from the bloodstream into tissues in the resolution of a pri-
mary infection is equally important to understand.
Intravital imaging has revealed that a key event in the selection
of blood-borne leukocytes for recruitment into tissues is their
capture, rolling, and arrest on the inside walls of blood vessels.
This depends on co-ordinated signaling of different types of
adhesion molecule, such as selectins and integrins, as well as
chemokine receptors following engagement by their respective
ligands on blood vessel endothelial cells. Virus-specific effector
CD8+ T cells upregulate the expression of a number of adhesion
molecules known to regulate the recruitment of activated or
effector T lymphocytes into sites of inflammation, including P-se-
lectin glycoprotein ligand (PSGL)-1, CD44, and the integrins
LFA-1 and VLA-4 (Austrup et al., 1997; DeGrendele et al., 1997;
Mora and von Andrian, 2006; Oehen and Brduscha-Riem,
1998; Siegelman et al., 2000; Lefranc¸ois and Marzo, 2006; Liu
et al., 2006). Depending on whether virus inoculation is via the
skin or the mucosa, upregulation of skin homing molecules
such as cutaneous lymphocyte antigen (CLA) or the mucosal
homing receptor a4b7 integrin could also impart tissue-specific
homing properties to virus-specific effector CD8+ T (Liu et al.,
2006). However, direct evidence for any of the homing-associ-
ated molecules expressed by activated virus-specific CD8+
T cells regulating their recruitment from the bloodstream into in-
fected tissues is lacking. In fact, a recent study found that the
chemokine receptor CXCR3, which is widely implicated in the
homing of interferon (IFN)-g secreting CD8+ T cells, had no role
in the recruitment of virus-specific CD8+ T cells from the blood-
stream into infected skin (Hickman et al., 2015).
A striking feature of virus-specific effector CD8+ T cells, regard-
less of the route of virus inoculation, is downregulation of the
adhesion molecule leukocyte-selectin (L-selectin)/CD62L. Low
expression of L-selectin on effector T cells (Kaech et al., 2002;
Figure 1. Cyclical Expression of L-selectin
during the Development of Virus-Specific
Effector CD8+ Cells In Vivo
(A) CFSE-labeled F5/B6 CD90.2 CD8+ T cells were
transferred i.v. to naive CD90.1 B6 mice, and 24 hr
later, mice were given vaccNP i.p. Lymphoid
organs were harvested 1 and 2 days after virus
challenge, and donor cells were analyzed for
dilution of CFSE in mediastinal LN (Med LN), axil-
lary LN (Ax LN), and ovary draining LN (ovDLN),
and spleen (blue) comparedwith control unlabeled
cells (gray).
(B) Bar chart shows means ± SEM for percentage
of CFSE-diluted donor cells (n = 3).
(C) Naive B6 mice were given 2 3 106 pfu of
vaccNP i.p., and ovary, heart, lung, and liver tis-
sues were collected after 5 days. Virus titers in
homogenized tissues were determined by plaque
assay. Symbols indicate individual mice.
(D) Naive F5/B6 CD90.2 CD8+ T cells were trans-
ferred i.v. to naive CD90.1 B6mice, and 24 hr later,
mice were injected with vaccNP. Representative
histograms show L-selectin expression on donor
CD8+ T cells in mediastinal LN (Med LN), periph-
eral blood (PB), and ovary.
(E) Bar chart shows means ± SEM for percentage
of L-selectin-positive donor cells (n = 4). d, day.
(F) Naive B6 mice were infected intranasally with
50 ffu influenza A virus (H1N1, PR8). Representa-
tive histograms show L-selectin expression on
PR8-specific tetramer (tet)-positive CD8+ T cells in
mediastinal LN, PB, and lungs.
(G) Bar chart shows means ± SEM for percentage
of L-selectin-positive PR8-specific CD8+ T cells
(n = 4).Mobley and Dailey, 1992; Richards et al., 2008), together with
homing studies, have suggested that L-selectin is not an impor-
tant homing molecule for sites of inflammation (Austrup et al.,
1997; Hirata et al., 2002; Mobley and Dailey, 1992; Mora and
von Andrian, 2006). Importantly, however, the recruitment of
T cells to skin allografts and peritoneal inflammation are signifi-
cantly reduced in L-selectin-deficient mice (Tang et al., 1997;
Tedder et al., 1995). L-selectin expression rapidly cycles between
high and low levels on in-vitro-activated T cells (Chaoet al., 1997).
Variable expression of L-selectin during T cell differentiationmay,
therefore, contribute to the conflicting data on whether L-selectin
is an important homing molecule on effector T cells in vivo.
In this study, we have used two evolutionary distinct viruses,
vaccinia and influenza, that infect mucosal and visceral organs,
respectively, and determined the role of L-selectin in regulating
the recruitment and function of effector CD8+ T cells. We demon-
strate that, following activation in LNs draining the site of inocu-
lation, L-selectin promotes the recruitment of effector CD8+
T cells to two different sites of virus replication: the lungs and
ovaries. Importantly, L-selectin is required for effective control
of virus replication in these organs. These results connect hom-
ing and a function of virus-specific CD8+ T cells to a single mole-
cule, L-selectin.CRESULTS
Cyclical Expression of L-selectin during Activation of
Virus-Specific Effector CD8+ T Cells In Vivo
Recombinant vaccinia virus expressing nucleoprotein peptide
NP366–374 (vaccNP) (Townsend et al., 1986) and CD8
+ T cells
expressing cognate F5 T cell receptor were used to determine
the levels of L-selectin expression at different stages of T cell
activation in vivo. First, the sites of T cell activation following
intraperitoneal administration of vaccNP were determined.
CFSE-labeled, naive F5/B6 CD8+ T cells were injected into
C57BL/6 (B6) mice, vaccNP was administered 24 hr later, and
lymphoid organs were analyzed for CFSE-labeled donor T cells
at 1 and 2 days postinfection (p.i.) (Figures 1A and 1B). Dilution
of CFSE was not detected until the second day following virus
administration and was largely restricted to the mediastinal LN.
T cell priming was low in LNs that do not drain the peritoneal cav-
ity (<10%) and slightly higher in the spleen. As described previ-
ously, high virus titers were found in the ovaries, but in contrast
to the parental Western Reserve strain (Zhao et al., 2011), virus
was not detected in other visceral organs (Figure 1C). Interest-
ingly, there was no evidence of T cell priming in LNs draining
the ovary (ovdLNs) at days 1 and 2 p.i. Therefore, CD8+ T cellell Reports 14, 760–771, February 2, 2016 ª2016 The Authors 761
activation following intraperitoneal administration of vaccNP
occurs within the first 2 days and is largely restricted to themedi-
astinal LN that drains the site of virus inoculation.
Next, we investigated changes in cell-surface levels of L-se-
lectin/CD62L following T cell activation in mediastinal LN and
recruitment to virus-infected ovaries (Figures 1D and 1E). Naive
CD8+ T cells express high levels of L-selectin. Following virus
administration, L-selectin is rapidly downregulated within 24 hr.
L-selectin re-expression begins during the second day of infec-
tion, when activated CD8+ T cells are still resident in mediastinal
LNs. By day 3, activated CD8+ T cells are detectable in the
bloodstream, and the majority (93% ± 1%) have re-expressed
L-selectin. CD8+ T cells start to infiltrate virus-infected ovaries
on day 3 p.i., at which time, the majority of cells still express
L-selectin (83% ± 1% positive). L-selectin expression gradually
declines to 21% ± 5% and 2% ± 0.1% positive at days 5 and
8 p.i., respectively. Cyclical expression of L-selectin was also
seen on endogenous, polyclonal virus-specific CD8+ T cells
following intranasal (i.n.) infection of B6 mice with influenza A
PR8 strain (Figures 1F and 1G). L-selectin was downregulated
and re-expressed at days 2 and 4 p.i., respectively, in the drain-
ing mediastinal LN, and L-selectin expression on virus-specific
CD8+ T cells in the bloodstream recruited to the lungs gradually
declined from 60% positive at day 4 to less than 5% positive at
day 8 p.i. These cyclical changes in L-selectin mirror the time
course of early ectodomain shedding, subsequent re-expres-
sion, and transcriptional silencing of L-selectin reported in vitro
(Chao et al., 1997) and raise the possibility that re-expressed
L-selectin could control the homing of activated CD8+ T cells
to virus-infected tissues.
Recruitment of CD8+ T Cells to Virus-Infected Organs Is
L-selectin Dependent
We hypothesized that, if T cell recruitment to virus-infected tis-
sues is L-selectin dependent, T cells expressing higher than
normal levels of L-selectin will be enriched and L-selectin-defi-
cient T cells will be decreased. To test this hypothesis, naive
F5 CD8+ T cells expressing either physiological levels of wild-
type L-selectin (F5/B6) or increased levels of L-selectin (F5/
LDP) (Figures 2A and 2B; Table S1) were transferred into B6
mice, the mice were challenged the following day with vaccNP
and ovaries, and ovdLNs and spleens were analyzed for donor
cells (Figure 2C). F5/B6 cells were found in ovaries at days 5,
8, and 12 p.i. (Figure 2D). The numbers did not change during
the course of the infection and, as described in Figure 1C, L-se-
lectin expression gradually fell. The number of F5/LDP cells in the
ovaries were 5- and 10-fold higher than F5/B6 cells at days 5 and
8, respectively (Figure 2D). By day 12, F5/LDP T cells had fallen in
number and were not significantly different from F5/B6 cells (Fig-
ure 2D), suggesting that expression of L-selectin, which is main-
tained on all activated F5/LDP cells (Figure 2C) (Richards et al.,
2008), does not improve survival or increase retention of virus-
specific CD8+ T cells at the site of infection. At day 5 p.i., F5/
LDP CD8+ T cells were enriched in ovdLNs, although this was
not significant and less than that seen in ovaries (Figure 2D).
The numbers of F5 CD8+ T cells expressing wild-type or
increased levels of L-selectin (LDP) in the spleen peaked at
day 8 andwere 50- to 1,000-fold higher than in ovaries or ovdLNs762 Cell Reports 14, 760–771, February 2, 2016 ª2016 The Authorsat all times analyzed. However, there was no enrichment of F5/
LDP over F5/B6 at any time point during virus infection, since
lymphocyte entry to the spleen is not L-selectin dependent (Fig-
ure 2D) (Arbone´s et al., 1994).
To determine the role of endogenous L-selectin, naive CD8+
T cells either sufficient (F5B6) or deficient (F5L-sel/) in L-selec-
tin were used. L-selectin expression was not required for entry
into mediastinal LN (Figure S1), and L-selectin expression had
no effect on T cell activation, since L-selectin-deficient and L-se-
lectin-sufficient CD8+ T cells were equally primed as measured
byonset of proliferation following virus administration (Figure S1).
However, the number of F5L-sel/ CD8+ T cells recruited to
vaccinia-infected ovaries was markedly lower than that of wild-
type cells at day 5 p.i. (Figure 2E). There were also reduced
numbers of F5L-sel/ CD8+ T cells in ovdLNs. Similar numbers
of F5 CD8+ T cells, sufficient or deficient in L-selectin, were found
in the spleen (Figure 2E). L-selectin expression also controlled
the recruitment of endogenously generated influenza-specific
CD8+ T cells to infected lungs. As shown in Figure 2F, the number
of PR8-specific CD8+ T cells in the lungs of polyclonal LDP mice
was 2-fold higher than that of B6 mice, whereas similar numbers
were found in the spleens.
These results, using two evolutionarily distinct viruses target-
ing different internal organs, demonstrate that the level of L-se-
lectin on activated CD8+ T cells controls recruitment to sites of
virus infection.
L-selectin Does Not Influence Priming, Activation, and
Differentiation of Virus-Specific CD8+ T Cells
Differences in recruitment of virus-specific CD8+ T cells suffi-
cient and deficient in L-selectin raised the possibility that L-se-
lectin affects the priming of CD8+ T cells, which, in turn, controls
the number of effector cells generated. Therefore, we deter-
mined the kinetics of T cell activation and differentiation during
the course of virus infection. The early activation antigen CD69
was upregulated by day 1 on wild-type F5/B6 CD8+ T cells in
mediastinal LN following vaccNP administration, and the kinetics
of CD69 upregulation on F5/LDP CD8+ T cells were similar (Fig-
ure 3A), suggesting that increased levels of L-selectin did not
alter interactions with antigen-presenting cells at the site of prim-
ing. CD69 was equally upregulated on L-selectin-deficient and
L-selectin-sufficient CD8+ T cells in mediastinal LNs following
i.n. administration of influenza virus, confirming that L-selectin
expression is not required to prime naive CD8+ T cells to virus-
derived peptides (Figure 3B).
To determine whether L-selectin affects the differentiation of
virus-specific CD8+ T cells during the course of infection,
expression of the late activation antigen CD44 on virus-specific
CD8+ T cells in virus-infected organs, LNs, and spleen was
measured. CD44 was upregulated to a similar extent and with
identical kinetics on T cells expressing wild-type L-selectin
(B6), expressing increased levels of L-selectin (LDP), or deficient
in L-selectin (L-sel/); on donor F5 T cells following intraperito-
neal vaccNP administration (Figures 3C and 3D) and on endog-
enously generated influenza-specific CD8+ T cells following i.n.
influenza administration (Figure 3E).
All donor T cells were fully activated (>90% CD44 positive) by
day 5 p.i., apart from in the spleen, where full activation was not
Figure 2. L-selectin-Dependent Recruitment of CD8+ T Cells to Virus-Infected Tissues
(A and B) Experimental plan (A) and density plots (B) showing F5 TCR expression on pre-transferred naive F5/B6 (blue) and F5/LDP (red) CD8+ T cells using NP68
tetramer (tet) and Vb11 staining, and fluorescence minus NP68 tetramer and Vb11 was used as fluorescence minus one (FMO). Overlaid histograms show CD44
expression, and gray histogram shows CD44 FMO. Density plots show L-selectin (CD62L) expression on CD8+ T cells, and gray density plot shows CD62L FMO.
In (B), percentage of positive cells is shown in the top right corners. d, day.
(C) Density plots show CD8, NP68 tetramer, and Vb11 triple-positive F5/B6 and F5/LDP donor cells post-transfer and background staining in mice that did not
receive F5 CD8+ T cells (No T cell). Representative density plots and percentages of donor F5/B6 and F5/LDP CD8+ T cells and L-selectin expression on donor
T cells in ovaries are shown.
(D) Total numbers of donor F5/B6 or F5/LDP CD8+ T cells at days 5, 8, and 12 post-vaccNP infection in ovary, ovdLN, and spleen. Two-way ANOVA with
Bonferroni post-test analysis.
(E) Total numbers of donor F5 CD8+ T cells expressing wild-type L-selectin (F5B6) or deficient in L-selectin (F5L-sel/) at day 5 p.i. in ovary, ovdLN, and spleen.
(F) Total numbers of endogenous, influenza-specific CD8+ T cells at day 8 p.i. with influenza A virus (PR8, H1N1) in lungs and spleens of B6 and LDP mice. i.n.,
intranasal.
Bar charts show means ± SEM. *p < 0.05; **p < 0.005; ***p < 0.0001.seen until day 8 p.i. (Figure 3C). CD44 has been shown to regu-
late effector T cell migration to sites of inflammation, but expres-
sion levels were similar on F5LDP, F5B6, and F5L-sel/ CD8+
T cells throughout the course of virus infection. The expression
of other adhesion molecules that regulate effector T cell migra-Ction, such as LFA-1 and VLA-4, as well as inflammation-associ-
ated chemokine receptors, CCR5 and CXCR3, were also equally
upregulated on activated F5LDP, F5B6, and F5L-sel/ CD8+
T cells (Figure S2). Together, these results demonstrate clearly
that L-selectin does not influence CD8+ T cell priming inell Reports 14, 760–771, February 2, 2016 ª2016 The Authors 763
Figure 3. L-selectin Expression Does Not
Affect the Activation or Differentiation of
CD8+ T Cells following intraperitoneal or
Intranasal Virus Administration
(A and B) Representative plots show (A) percent-
ages of CD69-positive F5/B6 and F5/LDP CD8+
T cells in mediastinal LN (Med LN) (day 1 p.i. with
vaccNP) and (B) percentages of CD69-positive
F5B6 and F5L-sel/ CD8+ T cells in mediastinal
LN at day 2 p.i. with H17 influenza virus. Bar charts
show means ± SEM.
(C and D) Representative plots show (C) CD44-
positive F5/B6 and F5/LDP at days 5, 8, and 12 p.i.
with vaccNP and (D) F5B6 and F5L-sel/ CD8+
T cells at day (d) 5 p.i. with vaccNP in ovary (thick
line), ovdLNs (thin line), and spleen (dashed line).
Bar charts show means ± SEM. CD44 median
fluorescence intensity (MFI).
(E) Representative plots show CD44-positive
polyclonal influenza-specific CD8+ T cells in lungs
(thick line) and spleen (dashed line) of B6 and LDP
mice (day 8 p.i. with PR8 influenza virus). Bar chart
shows means ± SEM. CD44 MFI.mediastinal LNs, the subsequent activation of primed T cells, or
the expression of other homing-associated molecules; instead,
the results indicate a role for L-selectin in the recruitment of acti-
vated CD8+ T cells from the bloodstream into virus-infected
tissues.
L-selectin-Dependent Homing of Activated CD8+ T Cells
to Virus-Infected Tissues
Two different approaches were used to determine the role of
L-selectin in activated CD8+ T cell homing. Based on the site
of priming and kinetics of CD8+ T cell activation, naive F5/LDP
CD8+ T cells were allowed to home and be primed before starting
treatment with MEL-14, a blocking antibody to L-selectin (Galla-
tin et al., 1983). Mice were injected with either 250 mg MEL-14 or764 Cell Reports 14, 760–771, February 2, 2016 ª2016 The Authorsimmunoglobulin G (IgG)2a isotype control
52 hr p.i., and donor cells were analyzed
at day 5 (Figures 4A and 4B). Strikingly,
MEL-14 reduced the number of donor
CD8+ T cells in infected ovaries by 85%
(Figure 4C). MEL-14 also reduced donor
CD8+ T cells in ovary-draining LNs but
had no effect in the spleen (Figure 4C).
Furthermore, to test whether L-selectin
affects the homing of endogenously pro-
duced effector CD8+ T cells, B6 mice
were intranasally infected with PR8 influ-
enza virus, and MEL-14 was adminis-
tered after T cell priming (Figures 4E
and 4F). Systemic L-selectin blockade
reduced the number of PR8-specific
CD8+ T cells in the lungs by 56% at day
4 and by 78% at day 8 p.i., demonstrating
a major role for L-selectin in the recruit-
ment of endogenously produced effector
CD8+ T cells to influenza-infected tissues(Figure 4G). The activation of virus-specific CD8+ T cells was not
influenced by L-selectin inhibition, as indicated by comparable
numbers of virus-specific T cells in the mediastinal LN and
spleen (Figures 4C and 4G) and comparable CD44 expression
in MEL-14 and IgG-treated virus-infected mice (Figures 4D
and 4H).
To confirm that the effect of MEL-14 was due to the blockade
of L-selectin on virus-specific CD8+ T cells and not due to
the blockade of L-selectin on host leukocytes, a competitive
short-term homing experiment was conducted using activated
CD8+ T cells sufficient and deficient in L-selectin.We used a con-
genic CD90.1/90.2 system, exploiting constant expression of
L-selectin on LDP effector CD8+ T cells (Figure 2C) (Richards
et al., 2008) and used L-selectin expression to distinguish these
Figure 4. Recruitment of L-selectin-Expressing CD8+ T Cells to Virus-Infected Tissues Is Inhibited by Anti-L-selectin Antibodies
(A–C) Presented are: (A) an experimental plan, (B) representative plots showing donor CD8+ T cells in ovaries at day (d) 5 p.i. with vaccNP, and (C) numbers of
donor cells in ovary, ovdLNs, and spleen of mice given either IgG2a or MEL-14 antibodies.
(D) Representative plots showing CD44-positive donor CD8+ T cells in ovary (thick line), ovdLNs (thin line), and spleen (dashed line) at day 5 p.i. with vaccNP in
mice given either IgG2a or MEL-14. Bar chart shows means ± SEM. CD44 MFI.
(E–G) Presented are: (E) an experimental plan, (F) representative plots showing influenza-specific CD8+ T cells in lungs of mice treated with IgG2a or MEL-14
antibodies at day 8 p.i. with PR8, and (G) numbers of influenza-specific CD8+ cells in lung, mediastinal LN (Med LN), and spleen. Two-way ANOVAwith Bonferroni
post-test.
(H) Representative plots showing CD44-positive influenza-specific CD8+ T cells in lung (thick line), mediastinal LN (thin line), and spleen (dashed line) at days 4
and 8 p.i. in mice injected with either IgG2a or MEL-14. CD44 MFI (days 4 and 8 p.i. with PR8).
Bar charts show means ± SEM. *p < 0.05; **p < 0.005.
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Figure 5. L-selectin Expression by Effector CD8+ T Cells Promotes Homing to Virus-Infected Tissues
(A and B) Presented are: (A) an experimental plan and (B) representative plots showing percentages of a 1:1mix of in-vitro-activated F5LDP (CD90.2+CD62L+) and
F5L-sel/ (CD90.2+CD62L) CD8+ T cells pre- and post-transfer in ovary, ovdLN, axillary LN (Ax LN), inguinal LN (Ing LN), mediastinal LN (Med LN), spleen,
and PB.
(C) Bar chart shows means ± SEM.
(D and E) Presented are: (D) an experimental plan and (E) bar chart showingmeans ±SEM for percentages of in-vivo-activated F5LDP and F5L-sel/CD8+ T cells
pre- and post-transfer in ovary, ovdLN, inguinal LN, spleen, and PB. Two-way ANOVA with Bonferroni post-tests.
***p < 0.0001.from L-sel/ donor T cells in the same host. CD90.1 B6 mice
were inoculated with vaccNP and intravenously injected 3 days
later with a 1:1 mixture of either in vitro (Figure 5A) or in vivo (Fig-
ure 5D) activated F5LDP and F5L-sel/ CD8+ T cells. Three
hours later, donor cells in different tissue compartments were
identified as CD8+, CD90.2+, and either CD62L+ or CD62L (Fig-
ure 5B). L-selectin/CD62L-expressing CD8+ T cells were highly
enriched over L-selectin-deficient cells in virus-infected ovaries
(Figures 5C and 5E). The ratio of L-selectin-positive and -nega-
tive T cells circulating in peripheral blood (PB) remained 1:1,
showing that the altered ratio in the ovaries was not simply due766 Cell Reports 14, 760–771, February 2, 2016 ª2016 The Authorsto the depletion of L-selectin-deficient T cells from the circulation
(Figures 5C and 5E). Interestingly, the enrichment of L-selectin-
positive over L-selectin-negative CD8+ T cells was substantially
higher, using effector cells generated in vivo rather than effector
T cells generated in vitro at 6.2-fold and 2.3-fold, respectively.
The majority of donor cells in ovdLNs were L-selectin positive,
as in two peripheral LNs known to be L-selectin dependent,
the axillary and inguinal LNs (Arbone´s et al., 1994). L-selectin-
positive T cells were not enriched in the mediastinal LN, which
shows clearly that, as found in the case of naive CD8+ T cells
(Figure S1), L-selectin is not a dominant homing receptor for
Figure 6. L-selectin Is Essential to Recruit
Protective, Virus-Specific CD8+ T Cells dur-
ing Primary Vaccinia Virus Infection
(A) Virus titers in ovaries of B6 and RAG1/ mice
at day (d) 5 and day 8 p.i. with vaccNP.
(B and C) Presented are: (B) an experimental plan
and (C) virus titers in ovaries of RAG1/ mice
supplemented with naive F5/B6 cells, F5/LDP
CD8+ T cells, or no T cells at day 8 p.i. with
vaccNP. One-way ANOVA with post-Tukey’s
multiple comparison test.
(D) Bar chart shows MFI of IL-2, TNF-a, IFN-g, and
granzyme B of donor F5/B6 and F5/LDP CD8+
T cells in ovaries at day 5 p.i. with vaccNP.
(E) Representative density plots show incorpora-
tion of EdU dye into the DNA of proliferating donor
F5/B6 and F5/LDP CD8+ T cells in the ovary at day
5 p.i. with vaccNP.
(F) Bar chart shows number of donor F5/LDPCD8+
T cells in ovaries of RAG1/ mice treated with
MEL-14 or IgG2a antibodies at day 5 p.i. with
vaccNP.
Bar charts show means ± SEM. *p < 0.05; **p <
0.005.effector CD8+ T cell homing to this LN during an ongoing immune
response to virus infection (Figure 5C). The enrichment of L-se-
lectin-expressing activated CD8+ T cells in ovaries of vaccinia-
infectedmice in the first 3 hr following intravenous administration
demonstrates that L-selectin controls homing of activated CD8+
T cells from the bloodstream into virus-infected tissues.
L-selectin-Dependent Homing of CD8+ TCells to Sites of
Vaccinia Virus Infection Confers Protective Anti-virus
Immunity
We hypothesized that, if L-selectin-expressing CD8+ T cells
home better to vaccinia-infected tissues, they may enhance vi-
rus clearance. Therefore, we tested the ability of F5 CD8+
T cells to clear vaccNP from immunodeficient mice. First, the ki-
netics of virus clearance from naive B6 and RAG/ mice were
compared to determine the optimal time point to assess lympho-
cyte-dependent virus clearance. As shown in Figure 6A, virus
titers in B6 and RAG/ mice were not significantly different at
5 days p.i.; however, lymphocyte-dependent virus clearance
was seen at day 8, when virus titers fell by 2 logs in B6, but not
in RAG/ mice. To determine whether L-selectin-expressing
CD8+ T cells promote virus clearance, CD8+ T cells from naive
F5/B6 or F5/LDP mice were injected into RAG/ mice. The
following day, T-cell-injected and non-T-cell-injected RAG/
mice were given vaccNP. All mice received interleukin (IL)-2 to
enhance the proliferation and survival of transferred CD8+
T cells in the absence of CD4+ T cell help (Figure 6B). Virus titers
were slightly reduced by transferring F5/B6 T cells. However, the
virus load was markedly reduced by transferring F5 CD8+ T cells
expressing LDP-selectin (Figure 6C). F5/LDP CD8+ T cells
secreted similar levels of cytotoxic mediators such as IFN-g, tu-Cell Reports 14, 760–771mor necrosis factor a (TNF-a), and gran-
zyme-B as wild-type cells (Figure 6D).
Both cell types show similar levels of pro-liferation measured by incorporation of EdU (5-ethynyl-20-deox-
yuridine) dye into the DNA of proliferating F5 CD8+ T cells
(Figure 6E). As found in B6 mice, the homing of LDP T cells to
virus-infected ovaries was completely inhibited by MEL-14 (Fig-
ure 6F). Together, these results suggest that the enhanced virus
clearance by CD8+ T cells expressing LDP-selectin is not due to
increased numbers of polyfunctional T cells or increased rate of
proliferation and, instead, correlates solely with increased L-se-
lectin-dependent homing to virus-infected tissues.
L-selectin Expression Promotes Virus Clearance during
Pulmonary Influenza Virus Infection
Although very informative for cellular studies of anti-virus im-
mune responses, the vaccinia model is of limited clinical rele-
vance. However, i.n. infection with influenza virus in mice can
be considered closest to the natural route of human influenza in-
fections. Having demonstrated that L-selectin regulates the
homing of virus-specific CD8+ T cells to influenza-infected lungs
(Figure 4G), we determined whether L-selectin confers anti-virus
immunity. L-sel/, B6, and LDP polyclonal mice were infected
intranasally with two different strains of influenza A viruses,
and lungs were harvested for virus titer 8 days p.i. Virus titers
were significantly lower in wild-type mice than in L-selectin-defi-
cient mice following infection with the pathogenic PR8 (H1N1) or
the non-pathogenic H17 (H3N2) strains of influenza virus,
demonstrating a role for L-selectin in the clearance of virus
from the lungs (Figures 7A and 7B). Interestingly, PR8 virus titers
were significantly lower in LDPmice than in B6mice. Since L-se-
lectin expression is restricted to T lymphocytes in LDPmice, this
strongly supports a role for L-selectin on T lymphocytes in the
control of virus replication. Interestingly, H17 titers were not, February 2, 2016 ª2016 The Authors 767
Figure 7. L-selectin Expression Promotes
Protective Anti-virus Immunity during Pri-
mary Influenza Virus Infection
(A and B) Virus titers in the lungs of polyclonal
L-sel/, B6, and LDP mice infected intranasally
with influenza A virus strain (A) PR8 (H1N1) and (B)
H17 (H3N2) at day (d) 8 p.i.
(C) Virus titers at day 7 p.i. in lungs of RAG/mice
supplemented with naive F5L-sel/, F5B6, or
F5LDP CD8+ T cells intravenously or no T cells
(control) and supplemented with IL-2 from days
2–5 p.i. with H17 influenza virus.
(D) Virus titers at day 5 p.i. in the lungs of RAG/
mice infected with H17 influenza virus following
installation of in-vitro-activated F5L-sel/, F5B6,
or F5LDP CD8+ T cells into the lungs. One-way
ANOVA with post-Tukey’s multiple comparison
test.
*p < 0.05; **p < 0.005; ***p < 0.0001.different in B6 and LDP mice (Figures 7A and 7B), which may
relate to the reduced pathogenicity of this virus. To determine
whether L-selectin on effector CD8+ T cells primed in draining
LNs is sufficient to confer protective immunity to influenza virus,
CD8+ T cells from naive F5L-sel/, F5B6, or F5LDP mice were
intravenously injected into RAG/ mice, and 24 hr later,
T-cell-injected and non-T-cell-injected RAG/ mice were in-
fected intranasally with H17 influenza virus and supplemented
with IL-2 between days 2 and 5 p.i. (Figure 7C). Virus titers in
RAG/ mice supplemented with L-selectin-sufficient CD8+
T cells were significantly reduced in comparison with non-T-
cell-injected mice, and the higher levels of L-selectin on F5LDP
T cells conferred increased protection against influenza virus
infection (Figure 7C). In contrast, virus titers in RAG/mice sup-
plemented with L-selectin-deficient CD8+ T cells were not statis-
tically different from those in non-T-cell-injected mice. The
increased homing of influenza-specific LDP CD8+ T cells to
virus-infected tissues (Figure 2), rather than increased prolifera-
tion or polyfunctionality (Figure 6), suggests that the inability of
L-selectin-deficient CD8+ T cells to control virus replication is
related to homing. To address this directly, in-vitro-generated
cytotoxic T lymphocytes sufficient and deficient in L-selectin
were instilled directly into the airways of influenza-infected
mice. Cytotoxic T lymphocytes delivered intratracheally were
able to control virus replication independently of L-selectin
expression (Figure 7D). These data, therefore, demonstrate
that, following priming in draining LNs and their release into the
bloodstream, L-selectin is essential for the recruitment of protec-
tive, virus-specific CD8+ T cells into infected tissues.768 Cell Reports 14, 760–771, February 2, 2016 ª2016 The AuthorsDISCUSSION
For the past 30 years, cellular immunolo-
gists have used L-selectin to determine
the activation and differentiation status
of T lymphocytes in different organs of
the body, but the transient nature and
role of L-selectin on activated T cells
have been ignored. In this study, weshow that L-selectin reversibly cycles between high and low
expression during the differentiation of virus-specific effector
CD8+ T cells in vivo. Importantly, although L-selectin is downre-
gulated within 24 hr at the site of priming in LNs, L-selectin
re-expression starts before activated CD8+ T cells exit LNs. Acti-
vated CD8+ T cells entering the circulation have fully re-ex-
pressed L-selectin, and this re-expressed L-selectin regulates
homing to virus-infected tissues. Furthermore, by promoting
homing, L-selectin expression confers protective immunity to
two evolutionarily distinct viruses during primary infection of
different internal organs, demonstrating a critical role for this bio-
logical process in anti-virus CD8+ T cell immunity.
We used two different viruses and routes of inoculation where
CD8+ T cell priming was restricted to a single LN and productive
virus replication was restricted to a single tissue, lung or ovary.
This allowed the kinetics and location of L-selectin downregula-
tion and re-expression early after T cell activation to be deter-
mined in vivo. Activated T cells start to exit the LN 3 days
following antigen administration (Fazilleau et al., 2009; Ford
and Atkins, 1971; Mempel et al., 2004), and, as shown in this
study, activated CD8+ T cells are recruited into virus-infected tis-
sue as early as day 3 p.i. when they have fully re-expressed L-se-
lectin. We found no evidence that L-selectin regulates the
recruitment or priming of CD8+ T cells in mediastinal LN. Naive,
L-selectin-deficient CD8+ T cells migrated from the bloodstream
into mediastinal LN as efficiently as L-selectin-sufficient CD8+
T cells, a mechanism thought to be dependent upon a4b7 integ-
rin binding to MAdCAM-1 on high endothelial venules (HEV), as
reported in other mucosal-tissue-associated LNs (Bargatze
et al., 1995; Hamann et al., 1994). The kinetics of CD8+ T cell
activation measured by CD69 expression and cell proliferation
were similar in T cells deficient and sufficient in L-selectin. L-se-
lectin did not regulate the subsequent differentiation of effector
CD8+ T cells either, since the fraction of proliferating cells and
the expression of CD44 and other homing-associated mole-
cules, intracellular cytokines, and granzymes were similar in
L-selectin-sufficient and L-selectin-deficient T cells harvested
at days 5 and 8 from virus-infected tissues, draining LN, and
the spleen.
We used three different approaches to demonstrate that the
expression of L-selectin on activated CD8+ T cells promotes
homing to virus-infected tissues. First, the enrichment of LDP
T cells expressing increased levels of L-selectin (Galkina et al.,
2007) and the reduction in T cells deficient in L-selectin support
the hypothesis that L-selectin regulates the recruitment of virus-
specific T cells into infected organs.
Second, antibody blockade of L-selectin after T cells had
been activated in mediastinal LN reduced recruitment of donor-
and host-derived virus-specific effector CD8+ T cells by 56%–
85% during primary infection with vaccinia and influenza vi-
ruses. L-selectin blockade did not inhibit late priming of CD8+
T cells (after 52 hr) following influenza infection, since the
numbers of activated CD8+ T cells in the mediastinal LN and
spleen were not altered by MEL-14. There was also no evidence
that L-selectin controlled late priming in ovary draining LNs,
since the numbers of virus-specific CD8+ T cells in the spleen
were not altered by L-selectin blockade or L-selectin deficiency.
Although there was a slight enrichment of F5/LDP over F5/B6
CD8+ T cells in ovary-draining LNs at day 5 p.i., this likely re-
flects increased L-selectin-dependent homing of F5/LDP CD8+
T cells that have retained cell-surface L-selectin following exit
from mediastinal LN and entry into the bloodstream, rather
than increased priming.
The third approach was to demonstrate the role of L-selectin
in recruiting activated CD8+ T cells from the bloodstream into vir-
ally infected tissues in a competitive short-term homing assay.
Following injection in the bloodstream, L-selectin-sufficient
and L-selectin-deficient activated CD8+ T cells circulated
equally, but after 3 hr, F5LDP CD8+ T cells were significantly
enriched over F5L-sel/ cells from 50% in the bloodstream
to >85% in infected ovaries. Interestingly, in-vivo-generated
effector T cells showed greater enrichment of L-selectin-ex-
pressing CD8+ T cells than in-vitro-generated cells at 6.2- and
2.3-fold, respectively. This important finding suggests that the
role of L-selectin in regulating effector T cell recruitment from
the bloodstream into infected or inflamed tissues may be mark-
edly underestimated, and that the role of other adhesion path-
ways may be overestimated, if in-vitro-generated T cells are
used to study homing. The fact that L-selectin-deficient effector
CD8+ T cells are recruited into virus-infected tissues, albeit in
low numbers, suggests that other molecules can substitute for
L-selectin. Obvious candidates are the endothelial selectins.
However, the recruitment of endogenously activated CD8+
T cells to sites of virus-induced inflammation in the skin and
internal organs is unchanged in E- and P-selectin double-
knockout mice (Bartholdy et al., 2000). In contrast, E- and P-se-
lectins have been reported to regulate effector CD8+ T cellCrecruitment to hypersensitivity lesions in the skin (Hirata et al.,
2002). Together, these results suggest that roles for E- and P-se-
lectins, as opposed to L-selectin, in effector CD8+ T cell recruit-
ment may depend on the nature of the inflammatory stimulus
and/or cytokine activation of local blood vessels. These results,
combined with our own findings reported here, suggests that
L-selectin is the dominant selectin pathway used by effector
CD8+ T cells in virus-infected tissues. The ligand is distinct
from classical L-selectin ligands such as GlyCAM-1, CD34, po-
docalyxin, and MAdCAM-1, since MECA79 immunostaining of
CD31-positive blood vessels was not detected in virus-infected
lungs or ovaries.
Having demonstrated L-selectin-dependent homing of acti-
vated CD8+ T cells to virus-infected tissues, we determined
the impact of this pathway on virus elimination. Transfer of
CD8+ T cells to lymphocyte-deficient mice enhanced virus clear-
ance, and the effect of T cells expressing high levels of L-selec-
tin was greater (Figure 6C). Although L-selectin co-stimulates
T cell proliferation and regulates the activity of cytotoxic T lym-
phocytes in vitro (Murakawa et al., 1992; Nishijima et al., 2005;
Yang et al., 2011), the role of L-selectin in controlling vaccinia vi-
rus infection did not simply correlate with increased polyfunc-
tionality or hyperproliferation. (Figure 6D) but instead correlates
with increased homing. To determine whether L-selectin is
required to recruit protective, virus-specific T cells to other inter-
nal organs, mice were intranasally infected with influenza A
virus. Polyclonal LDP mice, which selectively express shed-
ding-resistant L-selectin on T cells (Galkina et al., 2003), were
better able to resist influenza A challenge than wild-type mice,
and L-selectin knockout mice were more susceptible to influ-
enza A infection. These findings demonstrate the essential role
of L-selectin in recruiting protective, virus-specific CD8+
T cells to virus-infected mucosal as well as visceral organs
and suggest that the effect of wild-type CD8+ T cells is limited
by the numbers that access the site of infection following
T-cell-receptor (TCR)-induced downregulation of L-selectin. It
is possible that loss of L-selectin expression by effector
T cells evolved as a trade-off to limit immune-mediated pathol-
ogy yet retain adaptive cell-mediated immune defense again
pathogens during a primary infection.
It was originally hypothesized that L-selectin downregulation
is required to redirect effector T cells away from LNs and allow
migration to sites of inflammation, but our previous studies
do not support this hypothesis (Richards et al., 2008), and,
as shown in this study, L-selectin expression actually pro-
motes homing of activated T cells to sites of virus infection.
Our new data demonstrate that cyclical L-selectin expression
forms a critical part of the arsenal of effector CD8+ T cells by
imparting the ability to home to virus infected tissues. It will
be important to dissect the mechanisms that control cyclical
expression of L-selectin in activated T cells, since the ‘‘window
of opportunity’’ for L-selectin-dependent, protective immunity
is time limited, and this may impact the persistence of immu-
nological memory to viruses and vaccines. The results pre-
sented here indicate that maintaining expression of L-selectin
on T cells boosts CD8+ T cell immunity, which may have clin-
ical relevance in adoptive T cell therapies for virus infections
or for tumors.ell Reports 14, 760–771, February 2, 2016 ª2016 The Authors 769
EXPERIMENTAL PROCEDURES
Mice
The generation of L-selectin transgenic and knockout mice have been
described previously (Arbone´s et al., 1994; Galkina et al., 2003), and the geno-
types of mice used in this study are listed in Table S1. C57BL/6 mice were
purchased from Harlan Laboratories or Charles River Laboratories. C57BL/6
RAG2/ mice were from the Francis Crick Institute. All other mice were
bred in house. All experiments were conducted according to Cardiff University
institutional guidelines and UK Home Office regulations.
Viruses
VaccNP (Cerundolo et al., 1997) was injected intraperitoneally (i.p.) at 2 3 106
plaque-forming units (pfu). Influenza A virus strains A/PuertoRico/8/34 (PR8,
H1N1) and E61-13-H17 (H17, H3N2) were obtained from the Francis Crick
Institute, and mice were infected intranasally with a split dose of 50 focus-
forming units (ffu) in 50 ml sterile PBS under light anesthesia, as described
previously (Lauder et al., 2013).
Virus Titers
For vaccNP, virus titers were determined using a plaque assay on 70%–80%
confluent TK cells as described previously (Jones et al., 2003). For PR8 and
H17, a virus titration assay was used as previously described (Bachmann et al.,
1999), except that serially diluted lung homogenates were incubated with 1.43
105 trypsinizedLuc9.1cloneofMadinDarbycaninekidney (MDCK)cells (Hossain
et al., 2010). Each stained, influenza-infected MDCK cell was recorded
immediately after staining as single ffu, and the total ffu per lungwere calculated.
CD8+ T Lymphocyte Isolation
Spleens and/or LNs were harvested from adult mice and mashed through a
70-mm cell strainer (BD Pharmingen). Red blood cells were lysed using red
blood cell lysis buffer (BioLegend), and lymphocytes were washed with ice-
cold PBS supplemented with 2% fetal calf serum (FCS). CD8+ T lymphocytes
were isolated using the MACS (magnetic-activated cell sorting) column nega-
tive selection technique (Miltenyi Biotec) according to the manufacturer’s in-
structions. After isolation, cells were stained with anti-CD8a antibody to check
the purity (>98%).
Adoptive Transfer of CD8+ T Cells
23 106 naive purified CD8+ T lymphocytes from F5/LDP, F5/B6, F5B6, or F5L-
sel/ mice (all CD90.2+) in 200 ml saline were injected intravenously (i.v.) into
the tail vein of groups of three or four age- and sex-matched CD90.2+ B6,
RAG1/, or RAG2/ mice and left for 24 hr to allow the transferred lympho-
cytes to circulate and equilibrate in the recipient mice. One group of mice was
injected with saline and used as a no-T-cell control. For the CD8+ T cell priming
experiment, naive CD8+ T cells were purified from spleens and then washed
with PBS and resuspended in 10 mM carboxyfluorescein succinimidyl ester
(CFSE; Life Technologies/Invitrogen), 2 mM PKH-26, or 2 mM Cell Vue Claret
(Sigma-Aldrich) and incubated in the dark for 10 min at room temperature.
Equal volumes of FCS were added, and the cells then washed twice with
PBS, re-suspended in saline, and injected into CD90.1+ B6 mice.
Flow Cytometry
Mice were euthanized, blood was collected by cardiac puncture, and tissues
were excised. Mediastinal, axillary, inguinal, and ovary-draining LNs, ovaries,
lungs, and spleens were harvested in PBS and mashed through a 70-mm
cell strainer. Lungs were digested in 1 mg/ml collagenase D (Roche) and
10 mg/ml DNase I (USB) for 45 min at 37C prior to mashing. Red cells were
lysed in blood, spleen, and lung preparations. Isolated cells were washed
with PBS and 2% FCS and stained with fixable viability dye (Amcyan; Invitro-
gen) as per manufacturer’s protocol, and cells were stained for tetramer and
cell-surface markers with a combination of antibodies listed in the Supple-
mental Experimental Procedures.
Short-Term Homing Assays
F5L-sel/ and F5/LDP CD8+ T cells were activated either in vitro or in vivo for
7 and 5 days, respectively. Cells were mixed 1:1 and transferred i.v. into770 Cell Reports 14, 760–771, February 2, 2016 ª2016 The AuthorsvaccNP-infected B6 mice at 3 days p.i. After 3 hr, organs were harvested,
and donor cells were analyzed as described in the Supplemental Experimental
Procedures.
Statistical Analysis and Figures
Linear results are presented as means ± SEM from three to six mice per group.
Viral titers in individual mice and median values pooled from two independent
experiments (3–12 mice per group) are shown on a log scale. Figures were
drawn, and statistical analyses were performed using GraphPad Prism soft-
ware, Mac version 5.1, and statistical significance between groups was deter-
mined using an unpaired Student’s t test, unless otherwise stated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.12.090.
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